Tome Biosciences Launches with $213M in Funding, Targets ‘New Era’ of Genomic Medicines

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 12, 2023 at 10:52: PM
via Biotech startup Tome Biosciences emerged from stealth on Tuesday armed with with $213 million in funding from prominent investors and technology licensed from from the Massachusetts Institute of Technology.

article source
 

<



Similar threads

cafead
Newly Launched Tome Biosciences Acquires Replace Therapeutics for $65M
Replies
0
Views
107
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching
Replies
0
Views
56
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bright Minds Biosciences launches Phase II trial of absence epilepsy treatment
Replies
0
Views
3
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pulse Biosciences launches first-in-human pulsed field ablation trial
Replies
0
Views
22
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Element Biosciences nets $277M ahead of new sequencer launch
Replies
0
Views
13
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote